Determination by Analytical Sieving: Particle-Size Distribution, Part III

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2002
Volume 26
Issue 12

The author discusses the use of analytical sieving to determine the size distribution of granular and course powders and describes proper sieve construction and USP General Test {786&#125.

External Link - article-40975.pdf

Articles in this issue
Generic Drugs Take Center Stage
Contract Services
Fifth Annual International Employment Survey
Sensitivity of Gelatin Raw Materials to Cross-Linking: The Influence of Bloom Strength, Type, and Source
Determination by Analytical Sieving: Particle-Size Distribution, Part III
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Roche to Invest $50 Billion in US Pharmaceuticals and Diagnostics

Patrick Lavery
April 22nd 2025
Article

The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple states.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Announces New Policy on Advisory Committee Members

Patrick Lavery
April 18th 2025
Article

The policy announced by Commissioner Martin A. Makary, MD, will not preclude employees of regulated companies from presenting their views to committees, and rare exceptions will be allowed.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

compounding pharmacist at work 2 | Image Credit: ©Nadia -stock.adobe.com

Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
April 18th 2025
Article

Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New CDMO Meribel Pharma Solutions Launches with 13 Sites in Europe

Patrick Lavery
April 16th 2025
Article

The new United Kingdom-based firm has sites located in France, Spain, and Sweden, thanks to an acquisition of Synerlab Group and several Recipharm facilities in 2024.